Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,739,814
  • Shares Outstanding, K 262,938
  • Annual Sales, $ 31,430 K
  • Annual Income, $ -292,070 K
  • 60-Month Beta 2.70
  • Price/Sales 52.44
  • Price/Cash Flow N/A
  • Price/Book 17.45
Trade SRNE with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 5.76
  • Number of Estimates 2
  • High Estimate 11.71
  • Low Estimate -0.20
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +1,504.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.57 +68.06%
on 01/04/21
11.05 unch
on 01/27/21
+3.16 (+40.05%)
since 12/24/20
3-Month
5.17 +113.73%
on 11/10/20
11.05 unch
on 01/27/21
+3.34 (+43.32%)
since 10/27/20
52-Week
1.55 +612.90%
on 03/18/20
19.39 -43.01%
on 08/10/20
+7.17 (+184.79%)
since 01/27/20

Most Recent Stories

More News
Scientists Still Relentlessly Working to Develop Newest, More Advanced Antiviral Therapies for COVID-19 Treatments

, /PRNewswire/ -- The antivirals market consists of sales of antiviral drugs and related services. Antiviral drugs reduce the replication of viruses at different stages. Various type of viral infections...

NNVC : 4.60 (+10.31%)
TTOO : 2.24 (-20.28%)
PFE : 37.00 (-0.83%)
SRNE : 11.05 (+6.05%)
MRNA : 148.50 (-2.26%)
Do Options Traders Know Something About Sorrento (SRNE) Stock We Don't?

Investors need to pay close attention to Sorrento (SRNE) stock based on the movements in the options market lately.

SRNE : 11.05 (+6.05%)
Thinking about buying stock in DBV Technologies, Endra Life Sciences, Precision BioSciences, Sorrento Therapeutics, or Aldeyra Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DBVT, NDRA, DTIL, SRNE, and ALDX.

DBVT : 5.54 (-3.49%)
DTIL : 12.10 (-2.41%)
ALDX : 11.56 (-1.28%)
NDRA : 2.59 (-9.12%)
SRNE : 11.05 (+6.05%)
Thinking about buying stock in Sundial Growers, Charah Solutions, Sorrento Therapeutics, Zomedica, or Novan?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, CHRA, SRNE, ZOM, and NOVN.

ZOM : 0.8910 (-9.06%)
NOVN : 1.2402 (-4.60%)
SNDL : 0.5185 (-7.41%)
SRNE : 11.05 (+6.05%)
CHRA : 3.68 (-6.60%)
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference:

SRNE : 11.05 (+6.05%)
3 Biotech Stocks on the Robinhood 100 to AVOID

The Robinhood app is popular among millennial investors. And as the Covid-19 pandemic focused attention on the biotech industry last year, many young investors rushed to bet on the sector. Though market...

CPRX : 3.63 (-1.89%)
VXRT : 8.85 (-5.65%)
SRNE : 11.05 (+6.05%)
Sorrento Therape Set to Possibly Pullback After Yesterday's Rally of 2.30%

Sorrento Therape (NASDAQ:SRNE) traded in a range yesterday that spanned from a low of $7.42 to a high of $7.72. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of...

SRNE : 11.05 (+6.05%)
Thinking about trading options or stock in Nio, Plug Power, Pfizer, Sorrento Therapeutics, or BioNTech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, PLUG, PFE, SRNE, and BNTX.

BNTX : 104.74 (-1.46%)
PLUG : 64.55 (-11.79%)
SRNE : 11.05 (+6.05%)
NIO : 57.92 (-3.96%)
PFE : 37.00 (-0.83%)
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy

and , /PRNewswire/ -- Celularity Inc. ("Celularity"), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies...

SRNE : 11.05 (+6.05%)
GXGX : 10.25 (unch)
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know

Sorrento Therapeutics (SRNE) closed the most recent trading day at $7.03, moving -0.57% from the previous trading session.

SRNE : 11.05 (+6.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

3rd Resistance Point 12.39
2nd Resistance Point 11.55
1st Resistance Point 10.99
Last Price 10.84
1st Support Level 9.59
2nd Support Level 8.75
3rd Support Level 8.19

See More

52-Week High 19.39
Fibonacci 61.8% 12.58
Last Price 10.84
Fibonacci 50% 10.47
Fibonacci 38.2% 8.36
52-Week Low 1.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar